| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
OVID sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.00M | - | - | |
| Other | 3.74M | $5.23M | - | |
| Dir | 217.6K | $557.0K | - | |
| Other | 156.3K | - | - | |
| CFO | 94.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Rona Jeffrey A | Cbfo | Sell | 8,541 | $1.45 | $12,384.45 | -8.8% | +69.0% | - | |
| Feb 23, 2026 | Alexander Margaret A.48 | President and CEO | Sell | 11,656 | $1.45 | $16,901.20 | -15.9% | +69.0% | - | |
| Feb 26, 2025 | Alexander Margaret A.48 | President and COO | Sell | 5,279 | $0.56 | $2,956.24 | -6.7% | -45.8% | +206.9% | |
| Feb 26, 2025 | Rona Jeffrey A | Cbfo | Sell | 3,902 | $0.56 | $2,185.12 | -5.4% | -45.8% | +206.9% | |
| Jan 27, 2025 | Alexander Margaret A.48 | President and COO | Buy | 6,810 | $0.73 | $4,971.30 | +24.2% | -52.2% | +147.3% | |
| Mar 18, 2024 | Levin Jeremy M | CEO | Buy | 18,248 | $2.76 | $50,364.48 | +0.5% | -71.1% | -83.1% | |
| Sep 12, 2022 | Tardio Jason | Chief Operating Officer | Sell | 17,344 | $2.15 | $37,289.60 | -100% | -15.2% | +68.2% | |
| Jul 14, 2021 | Rakhit Amit | President and CMO | Sale+OE | 34,017 | $3.71 | $126,203.07 | -4.5% | +1.9% | -45.1% | |
| Aug 28, 2020 | Levin Jeremy M | CEO | Buy | 8,488 | $5.84 | $49,569.92 | +0.1% | - | - | |
| Oct 8, 2019 | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Buy | 2,000,000 | $2.50 | $5,000,000.00 | +53.3% | - | - |